397 related articles for article (PubMed ID: 22882208)
21. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
22. Considerations in the use of microneedles: pain, convenience, anxiety and safety.
Jeong HR; Lee HS; Choi IJ; Park JH
J Drug Target; 2017 Jan; 25(1):29-40. PubMed ID: 27282644
[TBL] [Abstract][Full Text] [Related]
23. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration.
Sivamani RK; Stoeber B; Wu GC; Zhai H; Liepmann D; Maibach H
Skin Res Technol; 2005 May; 11(2):152-6. PubMed ID: 15807814
[TBL] [Abstract][Full Text] [Related]
24. Challenges and strategies in developing microneedle patches for transdermal delivery of protein and peptide therapeutics.
Wu F; Yang S; Yuan W; Jin T
Curr Pharm Biotechnol; 2012 Jun; 13(7):1292-8. PubMed ID: 22201589
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.
Duarah S; Sharma M; Wen J
Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972
[TBL] [Abstract][Full Text] [Related]
26. Microneedles for transdermal drug delivery: a systematic review.
Dharadhar S; Majumdar A; Dhoble S; Patravale V
Drug Dev Ind Pharm; 2019 Feb; 45(2):188-201. PubMed ID: 30348022
[TBL] [Abstract][Full Text] [Related]
27. Rapid fabrication method of a microneedle mold with controllable needle height and width.
Lin YH; Lee IC; Hsu WC; Hsu CH; Chang KP; Gao SS
Biomed Microdevices; 2016 Oct; 18(5):85. PubMed ID: 27565822
[TBL] [Abstract][Full Text] [Related]
28. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.
Milewski M; Brogden NK; Stinchcomb AL
Expert Opin Drug Deliv; 2010 May; 7(5):617-29. PubMed ID: 20205604
[TBL] [Abstract][Full Text] [Related]
29. Successful application of large microneedle patches by human volunteers.
Ripolin A; Quinn J; Larrañeta E; Vicente-Perez EM; Barry J; Donnelly RF
Int J Pharm; 2017 Apr; 521(1-2):92-101. PubMed ID: 28216463
[TBL] [Abstract][Full Text] [Related]
30. Enhanced skin delivery of vismodegib by microneedle treatment.
Nguyen HX; Banga AK
Drug Deliv Transl Res; 2015 Aug; 5(4):407-23. PubMed ID: 26069156
[TBL] [Abstract][Full Text] [Related]
31. [Design and manufacture of microneedles array for transdermal drug delivery].
Zhang JY; Zhao YJ; Yang XL
Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Jan; 30(1):33-8. PubMed ID: 16646423
[TBL] [Abstract][Full Text] [Related]
32. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique.
Donnelly RF; Majithiya R; Singh TR; Morrow DI; Garland MJ; Demir YK; Migalska K; Ryan E; Gillen D; Scott CJ; Woolfson AD
Pharm Res; 2011 Jan; 28(1):41-57. PubMed ID: 20490627
[TBL] [Abstract][Full Text] [Related]
33. Transdermal delivery of insulin using microneedle rollers in vivo.
Zhou CP; Liu YL; Wang HL; Zhang PX; Zhang JL
Int J Pharm; 2010 Jun; 392(1-2):127-33. PubMed ID: 20347024
[TBL] [Abstract][Full Text] [Related]
34. Characterization of microchannels created by metal microneedles: formation and closure.
Kalluri H; Kolli CS; Banga AK
AAPS J; 2011 Sep; 13(3):473-81. PubMed ID: 21732220
[TBL] [Abstract][Full Text] [Related]
35. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
Cahill EM; O'Cearbhaill ED
Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
[TBL] [Abstract][Full Text] [Related]
36. Nanocomposite-strengthened dissolving microneedles for improved transdermal delivery to human skin.
Yan L; Raphael AP; Zhu X; Wang B; Chen W; Tang T; Deng Y; Sant HJ; Zhu G; Choy KW; Gale BK; Prow TW; Chen X
Adv Healthc Mater; 2014 Apr; 3(4):555-64. PubMed ID: 24173960
[TBL] [Abstract][Full Text] [Related]
37. Microneedles for transdermal drug delivery: a minireview.
Vandervoort J; Ludwig A
Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
[TBL] [Abstract][Full Text] [Related]
38. Microneedles: bench to bedside.
Kolli CS
Ther Deliv; 2015; 6(9):1081-8. PubMed ID: 26419290
[TBL] [Abstract][Full Text] [Related]
39. Microneedle technologies for (trans)dermal drug and vaccine delivery.
van der Maaden K; Jiskoot W; Bouwstra J
J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
[TBL] [Abstract][Full Text] [Related]
40. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
